Department of Pharmacology, University of Tennessee Health Science Center, Memphis, TN 38163, USA.
Mol Cell Endocrinol. 2012 Apr 4;351(2):152-66. doi: 10.1016/j.mce.2012.01.004. Epub 2012 Jan 8.
Many of melatonin's actions are mediated through interaction with the G-protein coupled membrane bound melatonin receptors type 1 and type 2 (MT1 and MT2, respectively) or, indirectly with nuclear orphan receptors from the RORα/RZR family. Melatonin also binds to the quinone reductase II enzyme, previously defined the MT3 receptor. Melatonin receptors are widely distributed in the body; herein we summarize their expression and actions in non-neural tissues. Several controversies still exist regarding, for example, whether melatonin binds the RORα/RZR family. Studies of the peripheral distribution of melatonin receptors are important since they are attractive targets for immunomodulation, regulation of endocrine, reproductive and cardiovascular functions, modulation of skin pigmentation, hair growth, cancerogenesis, and aging. Melatonin receptor agonists and antagonists have an exciting future since they could define multiple mechanisms by which melatonin modulates the complexity of such a wide variety of physiological and pathological processes.
褪黑素的许多作用是通过与 G 蛋白偶联的膜结合褪黑素受体 1 型和 2 型(分别为 MT1 和 MT2)相互作用或间接与来自 RORα/RZR 家族的核孤儿受体介导的。褪黑素还与醌还原酶 II 酶结合,该酶先前被定义为 MT3 受体。褪黑素受体广泛分布于全身;在此,我们总结了它们在非神经组织中的表达和作用。关于褪黑素是否与 RORα/RZR 家族结合等问题仍存在一些争议。研究褪黑素受体的外周分布很重要,因为它们是免疫调节、内分泌、生殖和心血管功能调节、皮肤色素沉着、毛发生长、癌症发生和衰老的有吸引力的靶点。褪黑素受体激动剂和拮抗剂具有令人兴奋的未来,因为它们可以确定褪黑素调节如此广泛的生理和病理过程的复杂性的多种机制。